Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Active Treatment in Type 2 Diabetes With NASH

NCT04639414 is registered in ClinicalTrials.gov with German Diabetes Center as lead sponsor.

NCT NCT04639414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04639414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Active Treatment in Type 2 Diabetes With NASH
Lead sponsor
German Diabetes Center
Phase
Phase 4
Overall status
Completed
Start date
March 26, 2021
Completion date
November 17, 2025
Enrollment
192 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease (nafld), non-alcoholic steatohepatitis (nash), type 2 diabetes